Stocks To Watch: HCL Tech, RailTel, Tata Power, IndusInd Bank, Gensol, And Others
Stocks to watch: Shares of firms like HCL Tech, RailTel, Tata Power, IndusInd Bank, Gensol, and others will be in focus on Monday's trade
Stocks to Watch on March 10: Domestic markets traded within a narrow range on Friday, closing almost flat after two consecutive sessions of gains. Today, several stocks will be in focus due to various developments:
HCL Tech
related stories
Shiv Nadar has signed a gift deed transferring 47% of HCL Corp and Vama Delhi shares to his daughter, Roshni Nadar Malhotra.
RailTel
RailTel secured a work order worth Rs 28.29 crore from Northern Railway.
Tata Power
Tata Power Renewable Energy, a subsidiary of Tata Power, has signed a memorandum of understanding (MoU) with the Andhra Pradesh government to collaborate on renewable energy projects in the state.
Rice Stocks
Shares of L&T Foods, Kohinoor Foods, KRBL, Chaman Lal Setia, and GRM Overseas will be in focus today after the Indian government lifted the ban on broken rice exports. The status has been changed from “prohibited" to “free" with immediate effect.
Reliance Infrastructure
Reliance Infrastructure’s Board has approved a Scheme of Arrangement between the company and its wholly-owned subsidiary, Reliance Velocity Limited, involving their respective shareholders and providing for the amalgamation of RVL with the company.
IndusInd Bank
According to a Bloomberg report, Reliance Nippon Life Insurance Ltd is looking to acquire a 9.9% stake in the private lender.
Vodafone Idea
The Income-tax Department has imposed a penalty of Rs 10.79 crore on Vodafone Idea, alleging that the company failed to provide adequate documentation for inter-company transactions in the 2020-21 assessment year. Vodafone Idea intends to appeal the order.
Lupin
Lupin has launched Rivaroxaban Tablets USP, 2.5 mg, in the US after receiving final approval from the USFDA. The drug is used to reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD), and has estimated annual sales of $446 million in the US.
Biocon
Biocon Biologics, a subsidiary of Biocon Ltd, has reported successful results from a pivotal Phase 3 study in adult patients with moderate to severe chronic plaque psoriasis.
Thangamayil Jewellery
The company has approved the allotment of 36,42,857 fully paid-up equity shares at an issue price of Rs 1,400 per Rights equity share.
HFCL
HTL Limited, a subsidiary of HFCL, has received an order worth Rs 44.36 crore from the Indian Army for supplying Tactical Optical Fiber Cable Assemblies. The order is to be executed by July 2025.
JSW Steel
JSW Steel’s consolidated crude steel production for February 2025 stood at 24.07 lakh tonnes, marking a 12% YoY increase from 21.50 lakh tonnes in February 2024. The company’s capacity utilization for the month was 93.5%.
Gensol Engineering
The promoters of Gensol Engineering, under scrutiny for delayed bank loan payments, have sold approximately 2.37% of the company’s equity (9,00,000 shares) to unlock liquidity, which will be reinvested in the business.
G R Infraprojects
The company’s Board has approved the divestment of its 100% stake in GR Galgalia Bahadurganj Highway Pvt Ltd. Additionally, the Board has approved an interim dividend of Rs 12.50 per share for FY 2024-25.
Nazara Technologies
Nazara Technologies has divested its 94.85% stake in OpenPlay Technologies Pvt Ltd, which operated the Classic Rummy platform, to Moonshine Technology Pvt Ltd, the parent company of PokerBaazi, for Rs 104.33 crore.
Shilpa Medicare
The USFDA has issued a Form 483 with one observation after completing an inspection of Shilpa Medicare’s Unit-1 at the Raichur Plant, which was conducted between March 3-7, 2025.
Alembic Pharmaceuticals
Alembic Pharmaceuticals received a Form 483 with one procedural observation after the USFDA inspection of its Bioequivalence Facility in Vadodara between March 3-7, 2025.
Bhagyanagar India
The company has acquired a 51% stake in Crescentia Technology Pvt Ltd, which focuses on trading, distributing, and manufacturing solar energy-related products.
Narayana Hrudayalaya
The company’s subsidiary, Health City Cayman Islands Ltd (HCCI), has entered into a joint venture agreement with 2070 Health Inc., W Health Ventures GP LLC, and Everhope Oncology Pvt Ltd to establish healthcare centers in India for cancer treatment.
Oriental Rail Infrastructure
Oriental Rail Infra has received its first-ever order for the Vande Bharat project, valued at Rs 42.89 crore, from Rail Coach Factory (RCF), Kapurthala, Indian Railways.
Medicamen Biotech
Medicamen Biotech has entered into an agreement with a major South African conglomerate for registering and marketing its products in the region.
AstraZeneca Pharma
AstraZeneca Pharma India has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import and distribute Durvalumab for treating limited-stage small cell lung cancer (LS-SCLC) in India.
- Location :
- First Published: